While Saudi National Biotechnology Strategy sets forth an ambitious vision to become a global biotech hub by 2024, the Kingdom still faces critical gaps: limited infrastructure for clinical trials, fragmented access to biotech development components, and under-leveraged domestic IP assets. In parallel, attracting foreign investment and world-class biotech innovators remains essential to catalyze ecosystem maturity and global competitiveness. – SAUDI BIOTECHNOLOGY ACCELERATOR provides the solution…
Projected market value, driven by healthcare, genomics, and biomanufacturing
CAGR from 2024 to 2030, reflecting rapid sector expansion
High-quality employment in biotech R&D, manufacturing, and innovation
National commitment to RDI, fueling biotech transformation
Strategic impact on economic diversification under Vision 2030
Biotechnology Developed in Saudi Arabia and Exported Globally
We carefully select, targetly support growth and help biotech innovation go to market in Saudi Arabia, GCC, MENA, and globally
Biotech Engineering & AI
Regulatory & Clinical Affairs
Health Economics
Legal
Support
Manufacturing & Supply Chain
Education & Training
Market Access & Economy
Saudi Biotechnology Accelerator welcomes you to the introductory call.
Pioneering Saudi-based Biotechnology Accelerator, advancing biotech innovators’ journey, and helping to excel in the Global Markets, while contributing to the Saudi Biotechnology Ecosystem establishment and growth
© Saudi Biotechnology Accelerator - 2025